Hims & Hers Health Shares Outstanding 2020-2024 | HIMS

Hims & Hers Health shares outstanding history from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Hims & Hers Health shares outstanding for the quarter ending September 30, 2024 were 0.235B, a 11.87% increase year-over-year.
  • Hims & Hers Health 2023 shares outstanding were 0.209B, a 2.36% increase from 2022.
  • Hims & Hers Health 2022 shares outstanding were 0.205B, a 9.49% increase from 2021.
  • Hims & Hers Health 2021 shares outstanding were 0.187B, a 428.32% increase from 2020.
Hims & Hers Health Annual Shares Outstanding
(Millions of Shares)
2023 209
2022 205
2021 187
2020 35
2019 35
2018
Hims & Hers Health Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 235
2024-06-30 235
2024-03-31 229
2023-12-31 209
2023-09-30 210
2023-06-30 208
2023-03-31 207
2022-12-31 205
2022-09-30 205
2022-06-30 204
2022-03-31 203
2021-12-31 187
2021-09-30 200
2021-06-30 192
2021-03-31 153
2020-12-31 35
2020-09-30 36
2020-06-30 35
2020-03-31 35
2019-12-31
2019-09-30 5
2019-06-30 5
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.506B $0.872B
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Precipio (PRPO) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00